HMGCS2 and colonic neoplasm: MYC represses 3-hydroxymethylglutaryl-CoA synthase (HMGCS2) in colon cancer [128] and decreased expression of HMGCS2 is found in ccRCC [129] and hepatocellular carcinoma [130], associated with worse patient outcome.